Table 4. Prevalence and comparison of malnutrition by different assessment tools according to the indications of liver transplant and degree of ascites.
Number | Paremeters | SGA (N=54) [n (%)] | ||
---|---|---|---|---|
Normal | Moderate | Severe | ||
1 | Indication of LT | |||
HCV related CLD | 1 (16.7) | 14 (31.1) | 0 (0.0) | |
HBV related CLD | 0 (0.0) | 10 (22.2) | 0 (0.0) | |
HBV with HCC | 1 (16.7) | 0 (0.0) | 0 (0.0) | |
Ethanol + HCV CLD | 0 (0.0) | 4 (8.9) | 0 (0.0) | |
Ethanol related CLD | 0 (0.0) | 9 (20.0) | 3 (100.0) | |
HCC | 2 (33.3) | 1 (2.2) | 0 (0.0) | |
Cryptogenic CLD | 1 (16.7) | 5 (11.1) | 0 (0.0) | |
Auto-immuno CLD | 1 (16.7) | 0 (0.0) | 0 (0.0) | |
Obstructive jaundice | 0 (0.0) | 1 (2.2) | 0 (0.0) | |
HBV + HCV related CLD | 0 (0.0) | 1 (2.2) | 0 (0.0) | |
P value | 0.002* | |||
2 | Degree of ascites | |||
No | 5 (83.3) | 14 (31.1) | 0 (0.0) | |
Mild | 1 (16.7) | 3 (6.7) | 0 (0.0) | |
Tense | 0 (0.0) | 28 (62.2) | 3 (100) | |
P value | 0.030* |
Chi-square test, (n, %), *, P<0.05 (between different groups of indications of LT and between different degree of ascites). SGA, subjective global assessment; LT, liver transplant; CLD, chronic liver disease; HCV, hepatitis c virus; HBV, hepatitis B virus; HCC, hepatocellular carcinoma.